Parkinson’s disease managing reversible neurodegeneration

Parkinson’s disease managing reversible neurodegeneration

Marty Hinz,1 Alvin Stein,2 Ted Cole,3 Beth McDougall,4 Mark Westaway5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati, OH, 4CLEARCenter of Health, Mill Valley, CA, USA; 5Four Pillars Health, Brendale...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hinz M, Stein A, Cole T, McDougall B, Westaway M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Parkinson’s disease
L-dopa
carbidopa
B6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/864f8d4ee4da431d8d86580a3e5f76d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:864f8d4ee4da431d8d86580a3e5f76d3
record_format dspace
spelling oai:doaj.org-article:864f8d4ee4da431d8d86580a3e5f76d32021-12-02T02:34:46ZParkinson’s disease managing reversible neurodegeneration1178-2021https://doaj.org/article/864f8d4ee4da431d8d86580a3e5f76d32016-04-01T00:00:00Zhttps://www.dovepress.com/parkinsonrsquos-disease-managing-reversible-neurodegeneration-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Marty Hinz,1 Alvin Stein,2 Ted Cole,3 Beth McDougall,4 Mark Westaway5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati, OH, 4CLEARCenter of Health, Mill Valley, CA, USA; 5Four Pillars Health, Brendale, QLD, Australia Abstract: Traditionally, the Parkinson’s disease (PD) symptom course has been classified as an irreversible progressive neurodegenerative disease. This paper documents 29 PD and treatment-induced systemic depletion etiologies which cause and/or exacerbate the seven novel primary relative nutritional deficiencies associated with PD. These reversible relative nutritional deficiencies (RNDs) may facilitate and accelerate irreversible progressive neurodegeneration, while other reversible RNDs may induce previously undocumented reversible pseudo-neurodegeneration that is hiding in plain sight since the symptoms are identical to the symptoms being experienced by the PD patient. Documented herein is a novel nutritional approach for reversible processes management which may slow or halt irreversible progressive neurodegenerative disease and correct reversible RNDs whose symptoms are identical to the patient’s PD symptoms. Keywords: Parkinson’s disease, L-dopa, carbidopa, B6, neurodegenerationHinz MStein ACole TMcDougall BWestaway MDove Medical PressarticleParkinson’s diseaseL-dopacarbidopaB6neurodegenerationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 763-775 (2016)
institution DOAJ
collection DOAJ
language EN
topic Parkinson’s disease
L-dopa
carbidopa
B6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Parkinson’s disease
L-dopa
carbidopa
B6
neurodegeneration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Hinz M
Stein A
Cole T
McDougall B
Westaway M
Parkinson’s disease managing reversible neurodegeneration
description Marty Hinz,1 Alvin Stein,2 Ted Cole,3 Beth McDougall,4 Mark Westaway5 1Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, 2Stein Orthopedic Associates, Plantation, FL, 3Cole Center for Healing, Cincinnati, OH, 4CLEARCenter of Health, Mill Valley, CA, USA; 5Four Pillars Health, Brendale, QLD, Australia Abstract: Traditionally, the Parkinson’s disease (PD) symptom course has been classified as an irreversible progressive neurodegenerative disease. This paper documents 29 PD and treatment-induced systemic depletion etiologies which cause and/or exacerbate the seven novel primary relative nutritional deficiencies associated with PD. These reversible relative nutritional deficiencies (RNDs) may facilitate and accelerate irreversible progressive neurodegeneration, while other reversible RNDs may induce previously undocumented reversible pseudo-neurodegeneration that is hiding in plain sight since the symptoms are identical to the symptoms being experienced by the PD patient. Documented herein is a novel nutritional approach for reversible processes management which may slow or halt irreversible progressive neurodegenerative disease and correct reversible RNDs whose symptoms are identical to the patient’s PD symptoms. Keywords: Parkinson’s disease, L-dopa, carbidopa, B6, neurodegeneration
format article
author Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_facet Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_sort Hinz M
title Parkinson’s disease managing reversible neurodegeneration
title_short Parkinson’s disease managing reversible neurodegeneration
title_full Parkinson’s disease managing reversible neurodegeneration
title_fullStr Parkinson’s disease managing reversible neurodegeneration
title_full_unstemmed Parkinson’s disease managing reversible neurodegeneration
title_sort parkinson’s disease managing reversible neurodegeneration
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/864f8d4ee4da431d8d86580a3e5f76d3
work_keys_str_mv AT hinzm parkinsonrsquosdiseasemanagingreversibleneurodegeneration
AT steina parkinsonrsquosdiseasemanagingreversibleneurodegeneration
AT colet parkinsonrsquosdiseasemanagingreversibleneurodegeneration
AT mcdougallb parkinsonrsquosdiseasemanagingreversibleneurodegeneration
AT westawaym parkinsonrsquosdiseasemanagingreversibleneurodegeneration
_version_ 1718402361122095104

Ejemplares similares